Specifically, the trial will examine the effectiveness of FMT in the treatment of a life-threatening complication in which the donor’s bone marrow immune cells attack the recipient’s organs and tissues.

Conventional treatments, such as immunosuppressant steroid drugs, are often ineffective in treating this disease when they affect the gut. However, research has already proven that the gut microbiome plays a critical role in maintaining health, and stool transplants are effective in treating intestinal infections. The study will involve ten patients who will be followed for a year in hopes of finding the specific microbe responsible for improving the condition of the disease.

News cannot be equated with a doctor’s prescription. Consult an expert before making a decision.

Source: Ferra

Previous articleRussians will be allowed to open bank accounts via smartphone video connectionScience and technology12:00 | 02 April 2023
Next articleApple wins appeal against UK antitrust investigationScience & Technology12:15 | 02 April 2023
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.


Please enter your comment!
Please enter your name here